|
Volumn 91, Issue 10, 2003, Pages 1199-1202
|
The dark side of platelet glycoprotein IIb/IIIa receptor inhibitors during percutaneous coronary interventions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOGEN RECEPTOR ANTAGONIST;
ANGINA PECTORIS;
CLINICAL TRIAL;
CORONARY STENT;
DATA ANALYSIS;
DIABETES MELLITUS;
DRUG LABELING;
EDITORIAL;
ENZYME BLOOD LEVEL;
HEART ARRHYTHMIA;
HEART FAILURE;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
MEDICAL PRACTICE;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RANDOMIZATION;
SHOCK;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
THROMBOSIS;
ULCER;
|
EID: 0037726524
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(03)00267-4 Document Type: Editorial |
Times cited : (3)
|
References (8)
|